Abstract
The Epstein–Barr virus latency-associated membrane protein LMP2A has been shown to activate the survival kinase Akt in epithelial and B cells in a phosphoinositide 3-kinase-dependent fashion. In this study, we demonstrate that the signalling scaffold Shb associates through SH2 and PTB domain interactions with phosphorylated tyrosine motifs in the LMP2A N-terminal tail. Additionally, we show that mutation of tyrosines in these motifs as well as shRNA-mediated downregulation of Shb leads to a loss of constitutive Akt-activation in LMP2A-expressing cells. Furthermore, utilization by Shb of the LMP2A ITAM motif regulates stability of the Syk tyrosine kinase in LMP2A-expressing cells. Our data set the precedent for viral utilization of the Shb signalling scaffold and implicate Shb as a regulator of LMP2A-dependent Akt activation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abdallah B, Hassan A, Benoist C, Goula D, Behr JP, Demeneix BA . (1996). A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. Hum Gene Ther 7: 1947–1954.
Beaufils P, Choquet D, Mamoun RZ, Malissen B . (1993). The (YXXL/I)2 signalling motif found in the cytoplasmic segments of the bovine leukaemia virus envelope protein and Epstein–Barr virus latent membrane protein 2A can elicit early and late lymphocyte activation events. EMBO J 12: 5105–5112.
Caldwell RG, Wilson JB, Anderson SJ, Longnecker R . (1998). Epstein–Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9: 405–411.
Casola S, Otipoby KL, Alimzhanov M, Humme S, Uyttersprot N, Kutok JL et al. (2004). B cell receptor signal strength determines B cell fate. Nat Immunol 5: 317–327.
Coligan JE, Dunn BM, Ploegh HL, Speicher DW, Wingfield PT . (2001). Current Protocols in Protein Science. John Wiley & Sons, Inc.: New York.
Coopman PJ, Do MT, Barth M, Bowden ET, Hayes AJ, Basyuk E et al. (2000). The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature 406: 742–747.
Courbard JR, Fiore F, Adelaide J, Borg JP, Birnbaum D, Ollendorff V . (2002). Interaction between two ubiquitin-protein isopeptide ligases of different classes, CBLC and AIP4/ITCH. J Biol Chem 277: 45267–45275.
Dianzani U, Funaro A, DiFranco D, Garbarino G, Bragardo M, Redoglia V et al. (1994). Interaction between endothelium and CD4+CD45RA+ lymphocytes. Role of the human CD38 molecule. J Immunol 153: 952–959.
Engels N, Merchant M, Pappu R, Chan AC, Longnecker R, Wienands J . (2001). Epstein–Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module. J Exp Med 194: 255–264.
Ettenberg SA, Magnifico A, Cuello M, Nau MM, Rubinstein YR, Yarden Y et al. (2001). Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex. J Biol Chem 276: 27677–27684.
Fodor S, Jakus Z, Mócsai A . (2006). ITAM-based signaling beyond the adaptive immune response. Immunology Lett 104: 29–37.
Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK et al. (1995). The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81: 727–736.
Fruehling S, Lee SK, Herrold R, Frech B, Laux G, Kremmer E et al. (1996). Identification of latent membrane protein 2A (LMP2A) domains essential for the dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction. J Virol 70: 6216–6226.
Grande SM, Ross SR, Monroe JG . (2006). Viral immunoreceptor-associated tyrosine-based activation motifs: potential players in oncogenesis. Future Oncol 2: 301–310.
Graham FL, Smiley J, Russell WC, Nairn R . (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36: 59–74.
Harlowe E, Lane D . (1988). Antibodies, A Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, New York.
Holmqvist K, Cross MJ, Rolny C, Hagerkvist R, Rahimi N, Matsumoto T et al. (2004). The adaptor protein Shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration. J Biol Chem 279: 22267–22275.
Ikeda M, Ikeda A, Longan LC, Longnecker R . (2000). The Epstein–Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases. Virology 268: 178–191.
Ikeda M, Ikeda A, Longnecker R . (2002). Lysine-independent ubiquitination of Epstein–Barr virus LMP2A. Virology 300: 153–159.
Ingham RJ, Raaijmakers J, Lim CS, Mbamalu G, Gish G, Chen F et al. (2005). The Epstein–Barr virus protein, latent membrane protein 2A, co-opts tyrosine kinases used by the T cell receptor. J Biol Chem 280: 34133–34142.
Karlsson T, Songyang Z, Landgren E, Lavergne C, Di Fiore PP, Anafi M et al. (1995). Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins. Oncogene 10: 1475–1483.
Katz E, Lareef MH, Rassa JC, Grande SM, King LB, Russo J et al. (2005). MMTV Env encodes an ITAM responsible for transformation of mammary epithelial cells in three-dimensional culture. J Exp Med 201: 431–439.
Koretzky GA, Abtahian F, Silverman MA . (2006). SLP76 and SLP65: complex regulation of signalling in lymphocytes and beyond. Nat Revs Immunol 6: 67–78.
Kunath T, Gish G, Lickert H, Jones N, Pawson T, Rossant J . (2003). Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype. Nat Biotechnol 21: 559–561.
Laux G, Perricaudet M, Farrell PJ . (1988). A spliced Epstein–Barr virus gene expressed in immortalized lymphocytes is by circularization of the linear viral genome. EMBO J 7: 769–774.
Lindholm CK, Henriksson ML, Hallberg B, Welsh M . (2002). Shb links SLP-76 and Vav with the CD3 complex in Jurkat T cells. Eur J Biochem 269: 3279–3288.
Longnecker R, Druker B, Roberts TM, Kieff E . (1991). An Epstein–Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase. J Virol 65: 3681–3692.
Lu J, Lin WH, Chen SY, Longnecker R, Tsai SC, Chen CL et al. (2006). Syk tyrosine kinase mediates Epstein–Barr virus latent membrane protein 2A-induced cell migration in epithelial cells. J Biol Chem 281: 8806–8814.
Lupher Jr ML, Rao N, Lill NL, Andoniou CE, Miyake S, Clark EA et al. (1998). Cbl-mediated negative regulation of the Syk tyrosine kinase. A critical role for Cbl phosphotyrosine-binding domain binding to Syk phosphotyrosine 323. J Biol Chem 273: 35273–35281.
Magnifico A, Ettenberg S, Yang C, Mariano J, Tiwari S, Fang S et al. (2003). WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation. J Biol Chem 278: 43169–43177.
Matskova L, Ernberg I, Pawson T, Winberg G . (2001). C-terminal domain of the Epstein–Barr virus LMP2A membrane protein contains a clustering signal. J Virol 75: 10941–10949.
Merchant M, Caldwell RG, Longnecker R . (2000). The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo. J Virol 74: 9115–9124.
Morrison JA, Raab-Traub N . (2005). Roles of the ITAM and PY motifs of Epstein–Barr virus latent membrane protein 2A in the inhibition of epithelial cell differentiation and activation of beta-catenin signaling. J Virol 79: 2375–2382.
Ota S, Hazeki K, Rao N, Lupher Jr ML, Andoniou CE, Drukeri B et al. (2000). The RING finger domain of Cbl is essential for negative regulation of the Syk tyrosine kinase. J Biol Chem 275: 414–422.
Rao N, Ghosh AK, Ota S, Zhou P, Reddi AL, Hakezi K et al. (2001). The non-receptor tyrosine kinase Syk is a target of Cbl-mediated ubiquitylation upon B-cell receptor stimulation. EMBO J 20: 7085–7095.
Scholle F, Bendt KM, Raab-Traub N . (2000). Epstein Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. J Virol 74: 10681–10689.
Scholle F, Longnecker R, Raab-Traub N . (2001). Analysis of the phosphorylation status of Epstein-Barr virus LMP2A in epithelial cells. Virology 291: 208–214.
Shaw G, Morse S, Ararat M, Graham FL . (2002). Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J 16: 869–871.
Silvennoinen O, Nishigaki H, Kitanaka A, Kumagai M, Ito C, Malavasi F et al. (1996). CD38 signal transduction in human B cell precursors. Rapid induction of tyrosine phosphorylation, activation of syk tyrosine kinase, and phosphorylation of phospholipase C-gamma and phosphatidylinositol 3-kinase. J Immunol 156: 100–107.
Swart R, Fruehling S, Longnecker R . (1998). Tyrosines 60, 64 and 101 of Epstein–Barr virus LMP2A are not essential for blocking B cell signal transduction. Virology 263: 485–495.
Swart R, Ruf IK, Sample J, Longnecker R . (2000). Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway. J Virol 74: 10838–10845.
Tomlinson CC, Damania B . (2004). The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway. J Virol 78: 1918–1927.
Welsh M, Mares J, Karlsson T, Lavergne C, Bréant B, Claesson-Welsh L . (1994). Shb is a ubiquitously expressed Src homology 2 protein. Oncogene 9: 19–27.
Welsh M, Songyang Z, Frantz JD, Trub T, Reedquist KA, Karlsson T et al. (1998). Stimulation through the T cell receptor leads to interactions between SHB and several signaling proteins. Oncogene 16: 891–901.
Welsh N, Makeeva N, Welsh M . (2002). Overexpression of the Shb SH2 domain-protein in insulin-producing cells leads to altered signaling through the IRS-1 and IRS-2 proteins. Mol Med 8: 695–704.
Winberg G, Matskova L, Chen F, Plant P, Rotin D, Gish G et al. (2000). Latent membrane protein 2A of Epstein–Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B cell tyrosine kinases. Mol Cell Biol 20: 8526–8535.
Zubiaur M, Izquierdo M, Terhorst C, Malavasi F, Sancho J . (1997). CD38 ligation results in activation of the Raf-1/mitogen-activated protein kinase and the CD3-zeta/zeta-associated protein-70 signaling pathways in Jurkat T lymphocytes. J Immunol 159: 193–205.
Acknowledgements
We thank Michael Welsh for generous gifts of reagents and for stimulating discussions. Fabio Malavasi kindly contributed the agonistic anti CD38 antibody IB4. We thank W Rod Hardy for providing the pMSCVpuro vector. This work was supported by grants from The Swedish Research Council, Grant K2002-16X-14227-01A and The Swedish Children's Cancer Foundation, PROJ01/18, to GW and LM, and from the Canadian Institutes for Health Research (CIHR) to TP. RJI is a Fellow of the Leukemia & Lymphoma Society. CKL is supported in part by a fellowship from the Wenner-Gren Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Matskova, L., Helmstetter, C., Ingham, R. et al. The Shb signalling scaffold binds to and regulates constitutive signals from the Epstein–Barr virus LMP2A membrane protein. Oncogene 26, 4908–4917 (2007). https://doi.org/10.1038/sj.onc.1210298
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1210298